Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vuk Zdinjak

Bioharvest Sciences Completes R&D Program, Produces Cannabis Biomass In Bioreactor

BioHarvest Sciences Inc.'s (OTCPK: CNVCF) (CSE:BHSC) (FSE:8MV) sales of its flagship VINIA product in Q1 2022 reached $787K, representing 112% growth compared to the same quarter of last year.

BioHarvest also had a strong quarter in R&D execution, highlighted by a March 23 declaration of successful completion of its cannabis R&D program with the production of cannabis biomass in large-scale industrial bioreactors - signaling the start of commercialization of the cannabis product. BioHarvest is in the process of transitioning the current R&D license to a production license.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.